Tumor DNA in blood and urine may predict cancer recurrence
NCT ID NCT05595408
First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time
Summary
This study looks at whether tumor DNA found in blood and urine can help predict if cancer will come back after surgery in people with a rare type of bladder and kidney cancer. Researchers will follow 84 patients who have had surgery and are receiving chemotherapy or immunotherapy. The goal is to see if these DNA tests can catch signs of remaining cancer earlier than standard scans.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this could lead to a simple blood or urine test to catch cancer recurrence early and guide treatment decisions.
- What could go wrong
- This is an observational study, not a treatment trial. It is small (84 people) and early, so results may not apply to all patients.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for MUSCLE INVASIVE UPPER TRACT UROTHELIAL CARCINOMA are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
Locations
-
Renji Hospital
RECRUITINGShanghai, Shanghai Municipality, 200127, China
Contact Phone: •••-•••-•••• Email: •••••@•••••